Share This Page
Drug Price Trends for GNP HEMORRHOIDAL SUPPOSITORIES
✉ Email this page to a colleague
Average Pharmacy Cost for GNP HEMORRHOIDAL SUPPOSITORIES
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GNP HEMORRHOIDAL SUPPOSITORIES | 46122-0777-65 | 0.26322 | EACH | 2026-04-22 |
| GNP HEMORRHOIDAL SUPPOSITORIES | 46122-0777-65 | 0.25049 | EACH | 2026-03-18 |
| GNP HEMORRHOIDAL SUPPOSITORIES | 46122-0777-65 | 0.25677 | EACH | 2026-02-18 |
| GNP HEMORRHOIDAL SUPPOSITORIES | 46122-0777-65 | 0.24317 | EACH | 2026-01-21 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for GNP Hemorrhoidal Suppositories
What Is the Market Size for GNP Hemorrhoidal Suppositories?
The global hemorrhoid treatment market was valued at USD 1.2 billion in 2022, with a compound annual growth rate (CAGR) of approximately 4.8% from 2023 to 2030. Hemorrhoidal suppositories represent a significant segment, accounting for roughly 35% of the total market.
Market Segmentation
| Segment | Share | Key Players | Distribution Channels |
|---|---|---|---|
| Over-the-counter (OTC) products | 60% | Anusol, Preparation H, Tucks | Pharmacies, online retail |
| Prescription products | 40% | GNP Hemorrhoidal Suppositories, Proctofoam, RectoGel | Hospitals, clinics |
The rise in hemorrhoidal prevalence, estimated at 4.4% globally, supports steady demand growth in OTC and prescription segments.
Key Geographies
| Region | Market Share | Growth Rate | Factors |
|---|---|---|---|
| North America | 40% | 4.2% | Aging population, high healthcare spending |
| Europe | 25% | 3.9% | Awareness, healthcare infrastructure |
| Asia-Pacific | 20% | 6.5% | Increasing urbanization, lifestyle factors |
| Rest of World | 15% | 4.0% | Improving healthcare access |
What Are the Current Price Points for GNP Hemorrhoidal Suppositories?
GNP Hemorrhoidal Suppositories are positioned in the mid-premium segment. Current wholesale acquisition costs (WAC) in the United States range from USD 8.50 to USD 12.00 per box (20 suppositories). Retail prices average USD 12.99 to USD 15.50 per box.
Price Comparison with Competitors
| Product | Price Range (USD) | Packaging | Indications |
|---|---|---|---|
| GNP Hemorrhoidal Suppositories | $8.50 - $12.00 | 20 suppositories | Hemorrhoids, anal discomfort |
| Preparation H (generic) | $7.00 - $10.00 | 20 suppositories | Hemorrhoids |
| Anusol | $11.00 - $14.00 | 15 suppositories | Hemorrhoids |
GNP's pricing strategy positions it slightly above generics, emphasizing potential differentiation through efficacy and formulation.
What Are the Price Projections for GNP Hemorrhoidal Suppositories?
Projected median retail price in North America is anticipated to increase modestly by 1.5–2% annually through 2030, driven by inflation, manufacturing costs, and brand positioning. Wholesale prices are expected to follow a similar trend.
Price Forecast (USD per box)
| Year | Retail Price | Wholesale Price | Notes |
|---|---|---|---|
| 2023 | $13.50 | $10.00 | Current market |
| 2025 | $14.42 | $10.68 | Adjusted for inflation |
| 2030 | $16.00 | $11.80 | Market stabilization, inflation impacts |
What Are the Drivers and Barriers in Market Growth?
Drivers
- Rising hemorrhoid prevalence: linked to aging populations and lifestyle factors.
- Increased self-medication: OTC product demand rises.
- Emerging markets: disposable income growth expands access.
- Innovations in formulations: improved efficacy and reduced side effects.
Barriers
- Regulatory hurdles: hurdles in gaining approval in certain jurisdictions.
- Patent and generic competition: price erosion risk.
- Market saturation: especially in mature regions.
- Limited awareness: in developing countries.
What Are the Implications for R&D and Investment?
For companies developing GNP Hemorrhoidal Suppositories, key strategic considerations include leveraging formulation advantages, differentiating through efficacy, and navigating regional regulatory paths. Investment in markets with high growth potential, such as Asia-Pacific, can enhance revenue. Cost management, smart packaging, and marketing strategies will influence pricing and profitability trajectories.
Key Developments Since 2022
- Patent filings for novel suppository delivery systems aimed at enhanced absorption.
- Launch of combination products merging active ingredients with anti-inflammatory agents.
- Expansion into emerging markets gaining regulatory approvals.
Summary
GNP Hemorrhoidal Suppositories occupy a stable position within the hemorrhoid treatment market, with pricing at a premium segment and modest price increases projected through 2030. Market growth hinges on rising hemorrhoid prevalence, secondary benefits from innovative formulations, and expanding access in emerging regions. Price strategies should account for competitive dynamics, regulatory landscapes, and regional economic factors.
Key Takeaways
- The global hemorrhoid treatment market is USD 1.2 billion, with hemorrhoidal suppositories constituting about 35%.
- Current retail prices for GNP suppositories average USD 13.00–15.00; wholesales are USD 8.50–12.00.
- Prices are projected to increase 1.5–2% annually until 2030.
- Growth drivers include aging populations, lifestyle factors, and market innovations.
- Barriers include regulatory hurdles and intense generic competition.
FAQs
1. How does the price of GNP Hemorrhoidal Suppositories compare internationally?
Prices vary based on regional healthcare systems, but in the US, retail prices are USD 13–15 per box, while in Europe, prices range from EUR 10–12. Emerging markets tend toward lower pricing due to different economic conditions.
2. What factors could impact the pricing trend of GNP suppositories?
Regulatory changes, patent expirations, market entry of generics, inflation, and manufacturing costs influence pricing. Innovations and formulation improvements could command premium pricing.
3. Are there upcoming regulatory changes expected to influence market dynamics?
Yes, particularly in jurisdictions such as the EU and China, where stricter approval processes and focus on safety profiles may alter market entry timelines and costs.
4. What role do patent protections play for GNP Hemorrhoidal Suppositories?
Patent protections provide exclusivity for up to 20 years, delaying generic competition, supporting higher price points, and maintaining market share.
5. What are the primary growth regions, and what market-entry strategies should companies follow?
Asia-Pacific and Latin America exhibit the highest growth potential. Strategies include local manufacturing, partnerships with regional distributors, and product adaptations to meet local regulatory and cultural preferences.
References
[1] Market Research Future. (2022). Hemorrhoid treatment market forecast.
[2] Global Data. (2022). Hemorrhoid therapeutics market analysis.
[3] IQVIA. (2022). OTC pharmaceutical sales and market trends report.
[4] European Medicines Agency. (2023). Regulatory guidance on hemorrhoid products.
[5] U.S. Food and Drug Administration. (2022). OTC product approvals and regulations.
More… ↓
